FEBS Letters | |
Arginine‐aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro | |
Lapidot, Aviva2  Evdokimov, Artem G1  Litovchick, Alexander2  | |
[1] Department of Structural Biology, The Weizmann Institute of Science, Rehovot 76100, Israel;Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel | |
关键词: Aminoglycoside-arginine conjugate; Transactivation responsive element RNA binder; HIV Tat/transactivation responsive element inhibition; Drug design; | |
DOI : 10.1016/S0014-5793(99)00092-7 | |
学科分类:生物化学/生物物理 | |
来源: John Wiley & Sons Ltd. | |
【 摘 要 】
HIV gene expression is crucially dependent on binding of the viral Tat protein to the transactivation RNA response element. A number of synthetic Tat-transactivation responsive element interaction inhibitors of peptide/peptoid nature were described as potential antiviral drug prototypes. We present a new class of peptidomimetic inhibitors, conjugates of l-arginine with aminoglycosides. Using a gel-shift assay and affinity chromatography on an l-arginine column we found that these compounds bind specifically to the transactivation responsive element RNA in vitro with K d values in the range of 20–400 nM, which is comparable to the K d of native Tat bound to the transactivation responsive element (10–12 nM). Confocal microscopy studies demonstrated that fluorescein-labelled conjugate penetrates into live cells. High affinity to the transactivation responsive element, low toxicity, and relative simplicity of synthesis make these compounds attractive candidates for antiviral drug design.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912020307275ZK.pdf | 361KB | download |